Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol

Neuropharmacology. 2016 Aug:107:181-188. doi: 10.1016/j.neuropharm.2016.03.027. Epub 2016 Mar 22.

Abstract

Mounting evidence indicates that ethanol (EtOH) exposure activates neuroimmune signaling. Alterations in pro-inflammatory cytokines after acute and chronic EtOH exposure have been heavily investigated. In contrast, little is known about the regulation of neurotransmission and/or modulation by anti-inflammatory cytokines in the brain after an acute EtOH exposure. Recent evidence suggests that interleukin-10 (IL-10), an anti-inflammatory cytokine, is upregulated during withdrawal from chronic EtOH exposure. In the present study, we show that IL-10 is increased early (1 h) after a single intoxicating dose of EtOH (5 g/kg, intragastric) in Sprague Dawley rats. We also show that IL-10 rapidly regulates GABAergic transmission in dentate gyrus neurons. In brain slice recordings, IL-10 application dose-dependently decreases miniature inhibitory postsynaptic current (mIPSC) area and frequency, and decreases the magnitude of the picrotoxin sensitive tonic current (Itonic), indicating both pre- and postsynaptic mechanisms. A PI3K inhibitor LY294002 (but not the negative control LY303511) ablated the inhibitory effects of IL-10 on mIPSC area and Itonic, but not on mIPSC frequency, indicating the involvement of PI3K in postsynaptic effects of IL-10 on GABAergic transmission. Lastly, we also identify a novel neurobehavioral regulation of EtOH sensitivity by IL-10, whereby IL-10 attenuates acute EtOH-induced hypnosis. These results suggest that EtOH causes an early release of IL-10 in the brain, which may contribute to neuronal hyperexcitability as well as disturbed sleep seen after binge exposure to EtOH. These results also identify IL-10 signaling as a potential therapeutic target in alcohol-use disorders and other CNS disorders where GABAergic transmission is altered.

Keywords: Alcohol; Anti-inflammatory; GABAA; Interleukin-10; Neuroimmune; mIPSC.

MeSH terms

  • Animals
  • Binge Drinking / metabolism
  • Brain / drug effects*
  • Brain / metabolism
  • Cells, Cultured
  • Central Nervous System Depressants / pharmacology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Ethanol / pharmacology*
  • Hypnotics and Sedatives / pharmacology
  • Inhibitory Postsynaptic Potentials / drug effects
  • Inhibitory Postsynaptic Potentials / physiology
  • Interleukin-10 / metabolism*
  • Male
  • Miniature Postsynaptic Potentials / drug effects
  • Miniature Postsynaptic Potentials / physiology
  • Neurons / drug effects
  • Neurons / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / metabolism
  • Sleep / drug effects
  • Sleep / physiology
  • Synaptic Transmission / drug effects*
  • Synaptic Transmission / physiology
  • Tissue Culture Techniques
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Central Nervous System Depressants
  • Hypnotics and Sedatives
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, GABA-A
  • Interleukin-10
  • Ethanol
  • gamma-Aminobutyric Acid